Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06438965
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-10
Brief Title:
MSOT as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases
Sponsor:
Childrens Hospital of Eastern Ontario
Organization:
Childrens Hospital of Eastern Ontario
Study Overview
Official Title:
Multispectral Optoacoustic Imaging MSOT as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases MSOT-NMD
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to learn if Multispectral Optoacoustic Tomographs MSOT works to diagnose and follow the course of neuromuscular diseases NMDs in children MSOT scans will be obtained from muscle region to measure hemomyoglobin collagen and lipid contentsignal and oxygenation in patients with neuromuscular diseases No additional research activities -other than MSOT - will be done during this study Existing clinical laboratory and imaging data from standard-of-care procedures will be correlated with the MSOT data The expected total duration of the study is approximately 36 months Repeated measurements will be done to evaluate disease progression and the value of MSOT in NMD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None